Liquidia Statistics
NASDAQ: LQDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
54.43-2.20 (-3.88%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Liquidia by the numbers
Liquidia has a market capitalization of $4.90 billion based on 90.11M shares outstanding. With trailing EPS of $-1.05, Liquidia is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.9% above its 50-day average and 1.1% below its 200-day average.
Average daily trading volume is 3.52M shares, or about $191.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LQDA valuation vs. peer median
| Metric | LQDA | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.90B | $4.74B | +4% |
| Avg. volume | 3.52M | 1.44M | +143% |
Peer median across 8 companies: ERAS, MANE, DNTH, PTCT, COGT, BLTE, TVTX, IONS.
Valuation
- Market cap
- $4.90B
- Forward P/E
- 15.12
- Price / sales (latest FY)
- 30.98
- EPS (TTM)
- $-1.05
- Shares outstanding
- 90.11M
Price and trading
- Previous close
- 56.63
- Open
- 56.49
- Day range
- 53.98 – 57.21
- 52-week range
- 22.31 – 93.61
- 52-week change
- +86.98%
- Beta
- —
- Volume
- 1.69M
- Average volume
- 3.52M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 4.90B
- Forward Pe
- 15.12
- Eps
- -1.05
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 93.61
- Week52 Low
- 22.31
- Avg Volume
- 3.52M
- Shares Outstanding
- 90.11M
- Ma50
- 47.77
- Ma200
- 55.02
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -41.85%
- Pct From52w Low
- 143.97%